Grassley Seeks FDA, CMS Clarification On Drug Compounding
This article was originally published in The Pink Sheet Daily
Executive Summary
In a letter to both agencies, Grassley asks FDA to what extent the federal government should assume oversight of drug compounding.
You may also be interested in...
FDA Cracks Down On Three Pharmacies Compounding Inhalation Drugs
In warning letters to the pharmacies, FDA says their compounding of mass amounts of drugs goes “well beyond” traditional compounding.
FDA Cracks Down On Three Pharmacies Compounding Inhalation Drugs
In warning letters to the pharmacies, FDA says their compounding of mass amounts of drugs goes “well beyond” traditional compounding.
Large-Scale Compounding Operations May Be A “Loophole” For Counterfeits, Slobodin Says
The House Energy & Commerce counsel says that some compounding operations now resemble manufacturing facilities rather than pharmacies.